ES2076526T3 - Antagonistas de bcrf1 para tratar infecciones del virus epstein-barr. - Google Patents

Antagonistas de bcrf1 para tratar infecciones del virus epstein-barr.

Info

Publication number
ES2076526T3
ES2076526T3 ES91907134T ES91907134T ES2076526T3 ES 2076526 T3 ES2076526 T3 ES 2076526T3 ES 91907134 T ES91907134 T ES 91907134T ES 91907134 T ES91907134 T ES 91907134T ES 2076526 T3 ES2076526 T3 ES 2076526T3
Authority
ES
Spain
Prior art keywords
bcrf1
antagonists
barr virus
virus infections
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91907134T
Other languages
English (en)
Inventor
Kevin W Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2076526T3 publication Critical patent/ES2076526T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PRESENTA UN METODO PARA TRATAR INFECCIONES EBV. EL METODO COMPRENDE LA ADMINISTRACION DE UNA CANTIDAD EFECTIVA DE UN ANTAGONISTA DE LA PROTEINA EBV, BCRF1. PREFERIBLEMENTE, EL ANTAGONISTA ES UN ANTICUERPO MONOCLONAL BLOQUEANTE ESPECIFICO PARA BCRF1, O UN FRAGMENTO O UN COMPUESTO DE UNION DERIVADO DEL MISMO. LA INVENCION INCLUYE EL USO DE UN ANTAGONISTA A BCRF1, POR EJEMPLO PARA LA FABRICACION DE UN MEDICAMENTO, PARA EL TRATAMIENTO DE LA ENFERMEDAD DEL VIRUS "EPSTEIN-BARR".
ES91907134T 1990-03-26 1991-03-22 Antagonistas de bcrf1 para tratar infecciones del virus epstein-barr. Expired - Lifetime ES2076526T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49898590A 1990-03-26 1990-03-26

Publications (1)

Publication Number Publication Date
ES2076526T3 true ES2076526T3 (es) 1995-11-01

Family

ID=23983319

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91907134T Expired - Lifetime ES2076526T3 (es) 1990-03-26 1991-03-22 Antagonistas de bcrf1 para tratar infecciones del virus epstein-barr.

Country Status (23)

Country Link
US (1) US5756342A (es)
EP (1) EP0522010B1 (es)
JP (1) JP2509774B2 (es)
KR (1) KR960004856B1 (es)
CN (1) CN1056245A (es)
AT (1) ATE126704T1 (es)
AU (1) AU650013B2 (es)
CA (1) CA2079230C (es)
DE (1) DE69112392T2 (es)
DK (1) DK0522010T3 (es)
ES (1) ES2076526T3 (es)
FI (1) FI924278L (es)
GR (1) GR3017920T3 (es)
HU (1) HUT63339A (es)
IE (1) IE70910B1 (es)
IL (1) IL97629A0 (es)
MX (1) MX9203522A (es)
MY (1) MY106163A (es)
NO (1) NO923749L (es)
OA (1) OA09674A (es)
PT (1) PT97108B (es)
WO (1) WO1991014451A1 (es)
ZA (1) ZA912138B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998010792A1 (en) * 1996-09-11 1998-03-19 Prendergast Patrick T Immune direction therapy
CN111574621B (zh) * 2020-04-30 2022-03-29 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一种中和eb病毒的单克隆抗体及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614810A (en) * 1984-09-24 1986-09-30 Pennwalt Corporation 4,5-dihydro-4-oxo-2-[(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic acids and derivatives thereof
US5231012A (en) * 1989-06-28 1993-07-27 Schering Corporation Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)

Also Published As

Publication number Publication date
FI924278A0 (fi) 1992-09-24
JP2509774B2 (ja) 1996-06-26
MX9203522A (es) 1992-07-01
HUT63339A (en) 1993-08-30
IL97629A0 (en) 1992-06-21
DE69112392D1 (de) 1995-09-28
EP0522010A1 (en) 1993-01-13
GR3017920T3 (en) 1996-01-31
FI924278A7 (fi) 1992-09-24
EP0522010B1 (en) 1995-08-23
IE910942A1 (en) 1991-10-09
AU650013B2 (en) 1994-06-09
IE70910B1 (en) 1997-01-15
DK0522010T3 (da) 1996-01-15
KR960004856B1 (ko) 1996-04-16
PT97108A (pt) 1991-11-29
CA2079230A1 (en) 1991-09-27
JPH05501116A (ja) 1993-03-04
US5756342A (en) 1998-05-26
DE69112392T2 (de) 1996-02-01
NO923749D0 (no) 1992-09-25
MY106163A (en) 1995-03-31
FI924278L (fi) 1992-09-24
ZA912138B (en) 1991-12-24
CA2079230C (en) 2001-02-13
CN1056245A (zh) 1991-11-20
WO1991014451A1 (en) 1991-10-03
ATE126704T1 (de) 1995-09-15
AU7588291A (en) 1991-10-21
PT97108B (pt) 1998-10-30
NO923749L (no) 1992-09-25
OA09674A (en) 1993-05-15

Similar Documents

Publication Publication Date Title
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
EA200100822A1 (ru) Baff, относящиеся к нему блокирующие агенты и их применение в стимуляции и ингибировании b-клеток и иммуноглобулинов в иммунных реакциях
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
ES2136654T3 (es) Herramientas para el diagnostico y tratamiento de la enfermedad de alzheimer.
DE69932084D1 (de) Antikörperfragmente zur lokalen Behandlung von Augenerkrankungen
EA200100524A1 (ru) Амиды антраниловой кислоты и их применение в качестве лекарственных средств
EA200101064A1 (ru) Лечение раковых заболеваний путем комбинированного введения доцетаксела с рекомбинантными гуманизированными моноклональными анти-her2 антителами
MA28289A1 (fr) Immunoglobulines
DE58909850D1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
ES2119185T3 (es) Tratamiento de enfermedades micobacterianas por administracion de productos de la proteina bactericida/que aumenta la permeabilidad.
ATE220688T1 (de) Tumor-zerstörende effekte von enterotoxinen und verwandten verbindungen
PT1200126E (pt) Utilização de anticorpos monoclonais específicos de cd28 para a preparação de uma composição farmacêutica para o tratamento de infecções virais
EP0869801A4 (en) THERAPEUTIC AND DIAGNOSTIC AGENTS FOR TREATING MICROBIAL INFECTIONS
GB9009106D0 (en) Processes and intermediates for synthetic antibody derivatives
BR0214363A (pt) Anticorpo, uso de um anticorpo, medicamento, método de fabricação de um medicamento e pacote farmacêutico para o tratamento de infecção
ATE66149T1 (de) Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden.
ES2062762T3 (es) Metodo para tratar el choque septico.
ES2076526T3 (es) Antagonistas de bcrf1 para tratar infecciones del virus epstein-barr.
NO912942D0 (no) Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere.
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
ATE154244T1 (de) Induzierung eines schutzes gegen virale infektionen
BR9808392A (pt) Uso de anticorpos de aves, e, processo para tratar infecções do trato respiratório.
DE3786173D1 (de) Menschlicher monoklonaler antikoerper und arzneimittel zur prophylaxe und behandlung von infektioesen krankheiten.
DE3874606D1 (de) Behandlung von viraler infektion.
DK0470989T3 (da) Anvendelse af monoklonale anti-beta2 mikroglobulin antistoffer

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 522010

Country of ref document: ES